Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weichel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 10, 2017
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb AntibodiesKristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2003
Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergyPeter Schmid-Grendelmeier, David Holzmann, Martin Himly, et al.
Protein Engineering, Design & Selection : PEDS|October 6, 2017
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cellsThorsten Gantke, Michael Weichel, Carmen Herbrecht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid LeukemiaUwe Reusch, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 10, 2017
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb AntibodiesKristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2003
Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergyPeter Schmid-Grendelmeier, David Holzmann, Martin Himly, et al.
Protein Engineering, Design & Selection : PEDS|October 6, 2017
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cellsThorsten Gantke, Michael Weichel, Carmen Herbrecht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid LeukemiaUwe Reusch, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Pageof 2